Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcium polystyrene sulfonate dose comparison in chronic kidney disease with hyperkalemia
ChiCTR-TRC-14004901Phase 4Recruiting
- Sponsor
- National Clinical Research Center for Kidney Disease
- Start
- Jul 2014
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of calcium polystyrene sulfonate in hyperkalemia and chronic kidney disease (CKD) (2 arms), sponsored by National Clinical Research Center for Kidney Disease. Primary endpoint: Serum potassium. Started Jul 2014; status: recruiting.
02
Drugs
calcium polystyrene sulfonate
03
Conditions
hyperkalemiachronic kidney disease (CKD)
Beyond the preview
Go deeper on ChiCTR-TRC-14004901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004901.